Compare ETFs: LABU
LABU
Comparison
Average Return
| Symbol | Year-to-date | 1 Year | 5 Years | 10 Years | Inception |
|---|---|---|---|---|---|
| LABU | -36.24% | -48.69% | -44.93% | -34.03% | -32.54% |
Top 25 Holdings
| LABU - Direxion Daily S&P Biotech Bull 3X Shares | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | n/a | Dreyfus Govt Cash Man Ins | 20.48% |
| 2 | n/a | Goldman Sachs Sterling FixInc Port Inc | 11.14% |
| 3 | n/a | Goldman Sachs Fin Gov 465 Institut | 10.24% |
| 4 | n/a | S&P Biotechnology Select Industry Index Swap | 8.32% |
| 5 | n/a | Dreyfus Trsry Securities Cash Mgmt | 5.00% |
| 6 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.66% |
| 7 | INSM | Insmed Incorporated | 1.64% |
| 8 | EXEL | Exelixis, Inc. | 1.61% |
| 9 | UTHR | United Therapeutics Corporation | 1.59% |
| 10 | NBIX | Neurocrine Biosciences, Inc. | 1.58% |
| 11 | REGN | Regeneron Pharmaceuticals, Inc. | 1.54% |
| 12 | VRTX | Vertex Pharmaceuticals Incorporated | 1.51% |
| 13 | NTRA | Natera, Inc. | 1.51% |
| 14 | INCY | Incyte Corporation | 1.51% |
| 15 | HALO | Halozyme Therapeutics, Inc. | 1.49% |
| 16 | GILD | Gilead Sciences, Inc. | 1.49% |
| 17 | ABBV | AbbVie Inc. | 1.49% |
| 18 | MRNA | Moderna, Inc. | 1.49% |
| 19 | AMGN | Amgen Inc. | 1.48% |
| 20 | BIIB | Biogen Inc. | 1.47% |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 1.46% |
| 22 | EXAS | Exact Sciences Corporation | 1.43% |
| 23 | BBIO | BridgeBio Pharma, Inc. | 1.40% |
| 24 | BPMC | Blueprint Medicines Corporation | 1.24% |
| 25 | TGTX | TG Therapeutics, Inc. | 1.12% |
| View LABU holdings | |||